Alesia B Sadosky

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions
    Alesia Sadosky
    Pfizer Global Outcomes Research, New York, New York 10017, USA
    Pain Pract 8:45-56. 2008
  2. ncbi Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey
    Marco daCosta Dibonaventura
    Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA
    Health Qual Life Outcomes 10:30. 2012
  3. ncbi Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey
    Marco daCosta Dibonaventura
    Pfizer, Inc, NY 10017, USA
    BMC Musculoskelet Disord 12:83. 2011
  4. ncbi Toward characterization and definition of fibromyalgia severity
    Stuart Silverman
    Cedars Sinai Medical Center, Los Angeles, CA, USA
    BMC Musculoskelet Disord 11:66. 2010
  5. ncbi Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
  6. ncbi Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia
    Alesia Sadosky
    Pfizer Global Outcomes Research, 235 East 42nd Street, New York, NY 10017, USA
    Health Qual Life Outcomes 7:12. 2009
  7. ncbi Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity
    Alesia B Sadosky
    Pfizer Inc, Global Health Economics and Outcomes Research, New York, NY 10017, USA
    Arthritis Res Ther 12:R162. 2010
  8. ncbi Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia
    Joseph C Cappelleri
    Pfizer Inc, Global Research and Development, New London, Connecticut 06320, USA
    Health Qual Life Outcomes 7:54. 2009
  9. ncbi Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results
    Joseph C Cappelleri
    Pfizer Inc, New London, Connecticut 06320, USA
    Pain Pract 9:348-53. 2009
  10. ncbi Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia
    Joseph C Cappelleri
    Pfizer Inc, Global Research and Development, 50 Pequot Avenue, New London, CT 06320, USA
    Sleep Med 10:766-70. 2009

Detail Information

Publications11

  1. ncbi A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions
    Alesia Sadosky
    Pfizer Global Outcomes Research, New York, New York 10017, USA
    Pain Pract 8:45-56. 2008
    ....
  2. ncbi Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey
    Marco daCosta Dibonaventura
    Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA
    Health Qual Life Outcomes 10:30. 2012
    ..abstract:..
  3. ncbi Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey
    Marco daCosta Dibonaventura
    Pfizer, Inc, NY 10017, USA
    BMC Musculoskelet Disord 12:83. 2011
    ..This study evaluated the impact of OA pain on healthcare resource utilization, productivity and costs in employed individuals...
  4. ncbi Toward characterization and definition of fibromyalgia severity
    Stuart Silverman
    Cedars Sinai Medical Center, Los Angeles, CA, USA
    BMC Musculoskelet Disord 11:66. 2010
    ..The objective of this study was to evaluate whether patient self-reported severity of FM is associated with severity of pain and sleep interference and the presence of core co-morbidities...
  5. ncbi Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    Robert M Bennett
    Oregon Health and Science University, Portland, Oregon, USA
    BMC Musculoskelet Disord 11:134. 2010
    ..The purpose of this study was to determine whether some of the clinical features of fibromyalgia (FM) that patients would like to see improved aggregate into definable clusters...
  6. ncbi Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia
    Alesia Sadosky
    Pfizer Global Outcomes Research, 235 East 42nd Street, New York, NY 10017, USA
    Health Qual Life Outcomes 7:12. 2009
    ..To evaluate the reliability of a one-week versus a four-week recall period of the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia (FM)...
  7. ncbi Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity
    Alesia B Sadosky
    Pfizer Inc, Global Health Economics and Outcomes Research, New York, NY 10017, USA
    Arthritis Res Ther 12:R162. 2010
    ..The objective of this study was to determine how patient-reported OA severity correlates with patient-reported outcomes including pain, function and productivity...
  8. ncbi Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia
    Joseph C Cappelleri
    Pfizer Inc, Global Research and Development, New London, Connecticut 06320, USA
    Health Qual Life Outcomes 7:54. 2009
    ..Sleep disturbances are a common and bothersome symptom of fibromyalgia (FM). This study reports psychometric properties of a single-item scale to assess sleep quality among individuals with FM...
  9. ncbi Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results
    Joseph C Cappelleri
    Pfizer Inc, New London, Connecticut 06320, USA
    Pain Pract 9:348-53. 2009
    ..7% (450 mg/day), and 12.5% (600 mg/day) more than placebo responders. This novel approach demonstrates that responder profiles can provide an enhanced interpretation of pain outcomes for patient care and symptom management...
  10. ncbi Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia
    Joseph C Cappelleri
    Pfizer Inc, Global Research and Development, 50 Pequot Avenue, New London, CT 06320, USA
    Sleep Med 10:766-70. 2009
    ..Sleep problems are a common symptom of fibromyalgia (FM). The objective of this study was to evaluate the Medical Outcomes Study (MOS) Sleep Scale as a measure of FM-related sleep problems...